[Seroprevalence of HBV and HCV in Blood Donors at the Blood Transfusion Center of Mohammed V Military Teaching Hospital in Rabat Morocco]
Overview
Authors
Affiliations
The purpose of this report is to present the findings of a retrospective study (2008-2009) to determine the seroprevalence of hepatitis B and C virus in blood donors at the Blood Transfusion Center of Military Teaching Hospital Mohammed V in Rabat, Morocco. Samples from 19,801 consecutive blood donors were analyzed by the immuno-enzymatic method (Enzyme Linked Immunosorbent Assay, third generation). The overall seroprevalence of HBV and HCV was 0.8% and 0.2% respectively. A total of 98 units were rejected because of elevated alanine transaminase. No case of co-infection was found. From 1991 to 2010, HBV and HCV seropositivity showed a significant declining trend. In spite of the low prevalence observed, this study confirms that the risk of transfusion transmitted infection exists and thus underlines the need to implement preventive strategies to improve blood transfusion safety.
Madihi S, Syed H, Lazar F, Zyad A, Benani A Biomed Res Int. 2020; 2020:7027169.
PMID: 32626758 PMC: 7305551. DOI: 10.1155/2020/7027169.
Prevalence of hepatitis B and C in blood transfusion center, Oujda Morocco (2013-2015).
Boubker S, Zerrouki N, Sidqi Z, Moussi M, El Mekkaoui A, Khannoussi W Pan Afr Med J. 2019; 33:163.
PMID: 31565125 PMC: 6756816. DOI: 10.11604/pamj.2019.33.163.18688.
Uwingabiye J, Zahid H, Unyendje L, Hadef R Pan Afr Med J. 2017; 25:185.
PMID: 28292147 PMC: 5326047. DOI: 10.11604/pamj.2016.25.185.6266.
A review of the infection-associated cancers in North African countries.
Hussein W, Anwar W, Attaleb M, Mazini L, Forsti A, Trimbitas R Infect Agent Cancer. 2016; 11:35.
PMID: 27512409 PMC: 4979152. DOI: 10.1186/s13027-016-0083-8.
[Seroprevalence of hepatitis C at the Military Hospital Mohammed V of Rabat].
Doblali T, Hadef R Pan Afr Med J. 2015; 19:182.
PMID: 25815103 PMC: 4366119. DOI: 10.11604/pamj.2014.19.182.5347.